Emerging roles of nodal and cripto-1: From embryogenesis to breast cancer progression

Breast Disease

Volumn 29, Issue , 2007, Pages 91-103

  Strizzi, Luigi ^a   Postovit, Lynne Marie ^a,c   Margaryan, Naira V ^a   Seftor, Elisabeth A ^a   Abbott, Daniel E ^a   Seftor, Richard E B ^a   Salomon, David S ^b   Hendrix, Mary J C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c WESTERN UNIVERSITY   (Canada)

Author keywords

Breast cancer; Cripto 1; Embryogenesis; Mammary development; Nodal

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MORPHOGEN; MORPHOLINE DERIVATIVE; NOTCH RECEPTOR; PROTEIN CRIPTO 1; PROTEIN NODAL; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

BIOCHEMISTRY; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STEM CELL; CANCER THERAPY; CARCINOMA CELL; DRUG MECHANISM; DRUG TARGETING; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HUMAN; MAMMARY GLAND; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 57049152264     PISSN: 08886008     EISSN: None     Source Type: Journal    
DOI: 10.3233/bd-2008-29110     Document Type: Review

References (99)

1. R. Kageyama, T. Ohtsuka and T. Kobayashi, The Hes gene family: repressors and oscillators that orchestrate embryogenesis, Development 134 (2007), 1243-1251.
2. S. Chiba, Notch signaling in stem cell systems, Stem Cells 24 (2006), 2437-2447.
3. U. Technau and C.B. Scholz, Origin and evolution of endoderm and mesoderm, Intl J Dev Biol 47 (2003), 531-539.
4. J. Maldonado-Saldivia, J. van den Bergen, M. Krouskos, M. Gilchrist, C. Lee, R. Li, A.H. Sinclair, M.A. Surani and P.S. Western, Dppa2 and Dppa4 are closely linked SAP motif genes restricted to pluripotent cells and the germ line, Stem Cells 25 (2007), 19-28.
5. Y. Babaie, R. Herwig, B. Greber, T.C. Brink, W. Wruck, D. Groth, H. Lehrach, T. Burdon and J. Adjaye, Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stemcells, Stem Cells 25 (2007), 500-510.
6. C.B. Moens and L. Selleri, Hox cofactors in vertebrate development, Dev Biol 291 (2006), 193-206.
7. A.V. Morales, H. Acloque, O.H. Ocana, C.A. de Frutos, V. Gold and M.A. Nieto, Snail genes at the crossroads of symmetric and asymmetric processes in the developing mesoderm, EMBO Rep 8 (2007), 104-109.
8. I. Germanguz, D. Lev, T.Waisman, C.H. Kim and I. Gitelman, Four twist genes in zebrafish, four expression patterns, Dev Dyn 236 (2007), 2615-2626.
9. A.F. Schier and M.M. Shen, Nodal signalling in vertebrate development, Nature 403 (2000), 385-389.
10. O. Andersson, P. Bertolino and C.F. Ibanez, Distinct and cooperative roles of mammalian Vg1 homologs GDF1 and GDF3 during early embryonic development, Dev Biol 311 (2007), 500-511.
11. V. Gupta, D.P. Harkin, H. Kawakubo and S. Maheswaran, Transforming Growth Factor-beta superfamily: Evaluation as breast cancer biomarkers and preventive agents, Curr Cancer Drug Targets 4 (2004), 165-182.
12. U.I. Ezeh, P.J. Turek, R.A. Reijo and A.T. Clark, Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma, Cancer 104 (2005), 2255-2265.
13. O. Adewumi, B. Aflatoonian, L. Ahrlund-Richter, M. Amit, P.W. Andrews, G. Beighton, P.A. Bello, N. Benvenisty, L.S. Berry, S. Bevan et al., Characterization of human embryonic stem cell lines by the International Stem Cell Initiative, Nat Biotech 25 (2007), 803-816.
14. Y.H. Loh, Q. Wu, J.L. Chew, V.B. Vega, W. Zhang, X. Chen, G. Bourque, J. George, B. Leong, J. Liu et al., The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells, Nat Genet 38 (2006), 431-440.
15. S. Assou, T. Lecarrour, S. Tondeur, S. Strom, A. Gabelle, S. Marty, L. Nadal, V. Pantesco, T. Reme, J.P. Hugnot et al., A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas, Stem Cells 25 (2007), 961-973.
16. L. Vallier, D. Reynolds and R.A. Pedersen, Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway, Dev Biol 275 (2004), 403-421.
17. D.P. Norris and E.J. Robertson, Asymmetric and node-specific nodal expression patterns are controlled by two distinct cisacting regulatory elements, Genes Dev 13 (1999), 1575-1588.
18. Y. Saijoh, S. Oki, C. Tanaka, T. Nakamura, H. Adachi, Y.T. Yan, M.M. Shen and H. Hamada, Two nodal-responsive enhancers control left-right asymmetric expression of Nodal, Dev Dyn 232 (2005), 1031-1036.
19. S.D. Vincent, D.P. Norris, J.A. Le Good, D.B. Constam and E.J. Robertson, Asymmetric Nodal expression in the mouse is governed by the combinatorial activities of two distinct regulatory elements, Mech Dev 121 (2004), 1403-1415.
20. A. Raya, Y. Kawakami, C. Rodriguez-Esteban, D. Buscher, C.M. Koth, T. Itoh, M. Morita, R.M. Raya, I. Dubova, J.G. Bessa et al., Notch activity induces Nodal expression and mediates the establishment of left-right asymmetry in vertebrate embryos, Genes Dev 17 (2003), 1213-1218.
21. L.T. Krebs, N. Iwai, S. Nonaka, I.C. Welsh, Y. Lan, R. Jiang, Y. Saijoh, T.P. O'Brien, H. Hamada and T. Gridley, Notch signaling regulates left-right asymmetry determination by inducing Nodal expression, Genes Dev 17 (2003), 1207-1212.
22. L.M. Postovit, E.A. Seftor, R.E. Seftor and M.J. Hendrix, Targeting Nodal in malignant melanoma cells, Expert Opin Ther Targets 11 (2007), 497-505.
23. J.M Topczewska, L.M. Postovit, N.V. Margaryan, A. Sam, A.R. Hess, W.W. Wheaton, B.J. Nickoloff, J. Topczewski and M.J. Hendrix, Embryonic and tumorigenic pathways converge via Nodal signaling: Role in melanoma aggressiveness, Nat Med 12 (2006), 925-932.
24. M.J. Hendrix, E.A. Seftor, R.E. Seftor, J. Kasemeier-Kulesa, P.M. Kulesa and L.M. Postovit, Reprogramming metastatic tumour cells with embryonic microenvironments, Nat Rev 7 (2007), 246-255.
25. W.Y. Choi, A.J. Giraldez and A.F. Schier, Target protectors reveal dampening and balancing of Nodal agonist and antagonist by miR-430, Science 318 (2007), 271-274.
26. A.F. Schier, Nodal signaling in vertebrate development, Annu Rev Cell Dev Biol 19 (2003), 589-621.
27. S. Beck, J.A. Le Good, M. Guzman, N. Ben Haim, K. Roy, F. Beermann and D.B. Constam, Extraembryonic proteases regulate Nodal signalling during gastrulation, Nat Cell Biol 4 (2002), 981-985.
28. J.A. Le Good, K. Joubin, A.J. Giraldez, N. Ben-Haim, S. Beck, Y. Chen, A.F. Schier and D.B. Constam, Nodal stability determines signaling range, Curr Biol 15 (2005), 31-36.
29. S. Tabibzadeh and A. Hemmati-Brivanlou, Lefty at the crossroads of stemness and differentiative events, Stem cells (Dayton, Ohio) 24 (2006), 1998-2006.
30. M.M. Shen, Nodal signaling: Developmental roles and regulation, Dev 134 (2007), 1023-1034.
31. D.S. Salomon, C. Bianco, A.D. Ebert, N.I. Khan, M. De Santis, N. Normanno, C. Wechselberger, M. Seno, K. Williams, M. Sanicola et al., The EGF-CFC family: Novel epidermal growth factor-related proteins in development and cancer, Endocr Relat Cancer 7 (2000), 199-226.
32. G. Minchiotti, S. Parisi, G. Liguori, M. Signore, G. Lania, E.D. Adamson, C.T. Lago and M.G. Persico, Membrane-anchorage of Cripto protein by glycosylphosphatidylinositol and its distribution during early mouse development, Mechanisms of development 90 (2000), 133-142.
33. G. Minchiotti, G. Manco, S. Parisi, C.T. Lago, F. Rosa and M.G. Persico, Structure-function analysis of the EGF-CFC family member Cripto identifies residues essential for nodal signalling, Development 128 (2001), 4501-4510.
34. Y.T. Yan, J.J. Liu, Y.E.C. Luo, R.S. Haltiwanger, C. Abate-Shen and M.M. Shen, Dual roles of Cripto as a ligand and coreceptor in the nodal signaling pathway, Mol Cell Biol 22 (2002), 4439-4449.
35. S.G. Schiffer, S. Foley, A. Kaffashan, X. Hronowski, A.E. Zichittella, C.Y.Yeo, K. Miatkowski, H.B. Adkins, B. Damon, M. Whitman et al., Fucosylation of Cripto is required for its ability to facilitate nodal signaling, J Biol Chem 276 (2001), 37769-37778.
36. S. Shi, C. Ge, Y. Luo, X. Hou, R.S. Haltiwanger and P. Stanley, The threonine that carries fucose, but not fucose, is required for cripto to facilitate nodal signaling, J Biol Chem (2007).
37. K. Watanabe, S. Hamada, C. Bianco, M. Mancino, T. Nagaoka, M. Gonzales, V. Bailly, L. Strizzi and D.S. Salomon, Requirement of glycosylphosphatidylinositol anchor of cripto-1 for 'trans' activity as a nodal co-receptor, J Biol Chem 2007).
38. C. Yeo and M. Whitman, Nodal signals to Smads through Cripto-dependent and Cripto-independent mechanisms, Mol Cell 7 (2001), 949-957.
39. C. Bianco, H.B. Adkins, C. Wechselberger, M. Seno, N. Normanno, A. De Luca, Y. Sun, N. Khan, N. Kenney, A. Ebert et al., Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells, Mol Cell Biol 22 (2002), 2586-2597.
40. E. Reissmann, H. Jornvall, A. Blokzijl, O. Andersson, C. Chang, G. Minchiotti, M.G. Persico, C.F. Ibanez and A.H. Brivanlou, The orphan receptorALK7and the Activin receptor ALK4 mediate signaling by Nodal proteins during vertebrate development, Genes Dev 15 (2001 , 2010-2022.
41. G. Liguori, M. Tucci, N. Montuori, R. Dono, C.T. Lago, F. Pacifico, F. Armenante and M.G. Persico, Characterization of the mouse Tdgf1 gene and Tdgf pseudogenes, Mamm Genome 7 (1996), 344-348.
42. J. Ding, L. Yang, Y.T. Yan, A. Chen, N. Desai, A. Wynshaw-Boris and M.M. Shen, Cripto is required for correct orientation of the anterior-posterior axis in the mouse embryo, Nature 395 (1998), 702-707.
43. N. Ben-Haim, C. Lu, M. Guzman-Ayala, L. Pescatore, D. Mesnard, M. Bischofberger, F. Naef, E.J. Robertson and D.B. Constam, The nodal precursor acting via activin receptors induces mesoderm by maintaining a source of its convertases and BMP4, Dev Cell 11 (2006), 313-323.
44. G.L. Liguori, A.C. Borges, D. D'Andrea, A. Liguoro, L. Goncalves, A.M. Salgueiro, M.G. Persico and J.A. Belo, Cripto-independent Nodal signaling promotes positioning of the A-P axis in the early mouse embryo, Dev Biol (2007).
45. D. D'Andrea, G. Liguori, A. Le Good, E. Lonardo, O. Amndersson, D. Constam, M. Persico and G. Minchiotti, Cripto promotes A-P axis specification independently of its stimulatory effect on Nodal autoinduction, J Cell Biol (2008) DOI: 10.1083/jcb.200709090.
46. S.K. Cheng, F. Olale, J.T. Bennett, A.H. Brivanlou and A.F. Schier, EGF-CFC proteins are essential coreceptors for the TGF-beta signals Vg1 and GDF1, Genes Dev 17 (2003), 31-36.
47. H.B. Adkins, C. Bianco, S.G. Schiffer, P. Rayhorn, M. Zafari, A.E. Cheung, O. Orozco, D. Olson, A. De Luca, L.L. Chen et al., Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo, J Clin Invest 112 (2003), 575-587.
48. P.C. Gray, C.A. Harrison andW. Vale, Cripto forms a complex with activin and type II activin receptors and can block activin signaling, Proc Natl Acad Sci USA 100 (2003), 5193-5198.
49. S. Kannan, M. De Santis, M. Lohmeyer, D.J. Riese, 2nd, G.H. Smith, N. Hynes, M. Seno, R. Brandt, C. Bianco, G. Persico et al., Cripto enhances the tyrosine phosphorylation of Shc and activates mitogen-activated protein kinase (MAPK) in mammary epithelial cells, J Biol Chem 272 (2007), 3330-3335.
50. A.D. Ebert, C. Wechselberger, S. Frank, B. Wallace-Jones, M. Seno, I. Martinez-Lacaci, C. Bianco, M. De Santis, H.K. Weitzel and D.S. Salomon, Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells, Cancer Res 59 (1999), 4502-4505.
51. C. Bianco, L. Strizzi, A. Rehman, N. Normanno, C. Wechselberger, Y. Sun, N. Khan, M. Hirota, H. Adkins, K.Williams et al., A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src, Cancer Res 63 (2003), 1192-1197.
52. E. Ruoslahti, Fibronectin and its integrin receptors in cancer, Adv Cancer Res 76 (1999), 1-20.
53. M.S. Ridyard and E.J. Sanders, Potential roles for focal adhesion kinase in development, Anatomy and embryology 199 (1999), 1-7.
54. L.J. Kornberg, Focal adhesion kinase expression in oral cancers, Head Neck 20 (1998), 634-639.
55. G.W. McLean, N.O. Carragher, E. Avizienyte, J. Evans, V.G. Brunton and M.C. Frame, The role of focal-adhesion kinase in cancer - a new therapeutic opportunity, Nat Rev Cancer 5 (2005), 505-515.
56. L. Strizzi, C. Bianco, N. Normanno, M. Seno, C. Wechselberger, B. Wallace-Jones, N.I. Khan, M. Hirota, Y. Sun, M. Sanicola et al., Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice, J Cell Physiol 201 (2004), 266-276.
57. M. Guzman-Ayala, N. Ben-Haim, S. Beck and D.B. Constam, Nodal protein processing and fibroblast growth factor 4 synergize to maintain a trophoblast stem cell microenvironment, Proc Natl Acad Sci USA 101 (2004), 15656-15660.
58. X. Zhou, H. Sasaki, L. Lowe, B.L. Hogan and M.R. Kuehn, Nodal is a novel TGF-beta-like gene expressed in the mouse node during gastrulation, Nature 361 (1993), 543-547.
59. J. Collignon, I. Varlet and E.J. Robertson, Relationship between asymmetric nodal expression and the direction of embryonic turning, Nature 381 (1996), 155-158.
60. W.C. Smith, R. McKendry, S. Ribisi, Jr. and R.M. Harland, A nodal-related gene defines a physical and functional domain within the Spemann organizer, Cell 82 (1995), 37-46.
61. Y.T. Yan, K. Gritsman, J. Ding, R.D. Burdine, J.D. Corrales, S.M. Price, W.S. Talbot, A.F. Schier and M.M. Shen, Conserved requirement for EGF-CFC genes in vertebrate left-right axis formation, Genes Dev 13 (1999), 2527-2537.
62. T. Tian and A.M. Meng, Nodal signals pattern vertebrate embryos, Cell Mol Life Sci 63 (2006), 672-685.
63. T. Tian and K. Burrage, Stochastic models for regulatory networks of the genetic toggle switch, Proc Natl Acad Sci USA 103 (2006), 8372-8377.
64. P.M. Iannaccone, X. Zhou, M. Khokha, D. Boucher and M.R. Kuehn, Insertional mutation of a gene involved in growth regulation of the early mouse embryo, Dev Dyn 194 (1992), 198-208.
65. F.L. Conlon, K.M. Lyons, N. Takaesu, K.S. Barth, A. Kispert, B. Herrmann and E.J. Robertson, A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse, Development 120 (1994), 1919-1928.
66. R. Toyama, M.L. O'Connell, C.V. Wright, M.R. Kuehn and I.B. Dawid, Nodal induces ectopic goosecoid and lim1 expression and axis duplication in zebrafish, Development 121 (1995), 383-391.
67. K. Gritsman, W.S. Talbot and A.F. Schier, Nodal signaling patterns the organizer, Development 127 (2000), 921-932.
68. R. Dono, L. Scalera, F. Pacifico, D. Acampora, M.G. Persico and A. Simeone, The murine cripto gene: Expression during mesoderm induction and early heart morphogenesis, Development 118 (1993), 1157-1168.
69. S.E. Johnson, J.L. Rothstein and B.B. Knowles, Expression of epidermal growth factor family gene members in early mouse development, Dev Dyn 201 (1994), 216-226.
70. C. Xu, G. Liguori, M.G. Persico and E.D. Adamson, Abrogation of the Cripto gene in mouse leads to failure of postgastrulation morphogenesis and lack of differentiation of cardiomyocytes, Development 126 (1999), 483-494.
71. J. Zhang, W.S. Talbot and A.F. Schier, Positional cloning identifies zebrafish one-eyed pinhead as a permissive EGF-related ligand required during gastrulation. Cell 92 (1998), 241-251.
72. K. Gritsman, J. Zhang, S. Cheng, E. Heckscher, W.S. Talbot and A.F. Schier, The EGF-CFC protein one-eyed pinhead is essential for nodal signaling, Cell 97 (1999), 121-132.
73. R.M. Warga and D.A. Kane, One-eyed pinhead regulates cell motility independent of Squint/Cyclops signaling, Dev Biol 261 (2003), 391-411.
74. Y. Saijoh, H. Adachi, R. Sakuma, C.Y. Yeo, K. Yashiro, M. Watanabe, H. Hashiguchi, K. Mochida, S. Ohishi, M. Kawabata et al., Left-right asymmetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2, Mol Cell 5 (2000), 35-47.
75. U. Gaio, A. Schweickert, A. Fischer, A.N. Garratt, T. Muller, C. Ozcelik, W. Lankes, M. Strehle, S. Britsch, M. Blum et al., A role of the cryptic gene in the correct establishment of the left-right axis, Curr Biol 9 (1999), 1339-1342.
76. A.F. Schier and W.S. Talbot, Nodal signaling and the zebrafish organizer, Int J Dev Biol 45 (2001), 289-297.
77. J.M. de la Cruz, R.N. Bamford, R.D. Burdine, E. Roessler, A.J. Barkovich, D. Donnai, A.F. Schier and M. Muenke, A loss-of-function mutation in the CFC domain of TDGF1 is associated with human forebrain defects, Hum Genet 110 (2002), 422-428.
78. N.J. Kenney, R.P. Huang, G.R. Johnson, J.X. Wu, D. Okamura, W. Matheny, E. Kordon, W.J. Gullick, G. Plowman, G.H. Smith et al., Detection and location of amphiregulin and Cripto-1 expression in the developing postnatal mouse mammary gland, Mol Reprod Dev 41 (1995), 277-286.
79. N.J. Kenney, H.B. Adkins and M. Sanicola, Nodal and cripto-1: Embryonic pattern formation genes involved in mammary gland development and tumorigenesis, J Mammary Gland Biol Neoplasia 9 (2004). 133-144.
80. C. Bianco, C. Wechselberger, A. Ebert, N.I. Khan, Y. Sun and D.S. Salomon, Identification of Cripto-1 in human milk, Breast Cancer Res Treat 66 (2001), 1-7.
81. M.L. De Santis, S. Kannan, G.H. Smith, M. Seno, C. Bianco, N. Kim, I. Martinez-Lacaci, B. Wallace-Jones and D.S. Salomon, Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3′-kinase-dependent pathway, Cell Growth Differ 8 (1997), 1257-1266.
82. C. Wechselberger, L. Strizzi, N. Kenney, M. Hirota, Y. Sun, A. Ebert, O. Orozco, C. Bianco, N.I. Khan, B. Wallace-Jones et al., Human Cripto-1 overexpression in the mouse mammary gland results in the development of hyperplasia and adenocarcinoma, Oncogene 24 (2005), 4094-4105.
83. Y. Sun, L. Strizzi, A. Raafat, M. Hirota, C. Bianco, L. Feigenbaum, N. Kenney, C. Wechselberger, R. Callahan and D.S. Salomon, Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis, Am J Pathol 167 (2005), 585-597.
84. R. Brandt, N. Normanno, W.J. Gullick, J.H. Lin, R. Harkins, D. Schneider, B.W. Jones, F. Ciardiello, M.G. Persico, F. Armenante et al., Identification and biological characterization of an epidermal growth factor-related protein: Cripto-1, J Biol Chem 269 (1994). 17320-17328.
85. A. Ciccodicola, R. Dono, S. Obici, A. Simeone, M. Zollo and M.G. Persico, Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells, Embo J 8 (1989), 1987-1991.
86. N. Kenney, G. Smith, M. Johnson, K. Rosemberg, D.S. Salomon and R. Dickson, Cripto-1 activity in the intact and ovariectomized virgin mouse mammary gland, Pathogenesis 1 (1997), 57-71.
87. N. Normanno, A. De Luca, C. Bianco, M.R. Maiello, M.V. Carriero, A. Rehman, C. Wechselberger, C. Arra, L. Strizzi, M. Sanicola et al., Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells, J Cell Physiol 198 (2004), 31-39.
88. C. Wechselberger, A.D. Ebert, C. Bianco, N.I. Khan, Y. Sun, B. Wallace-Jones, R. Montesano and D.S Salomon, Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells, Exp Cell Res 266 (2001), 95-105.
89. J.P. Thiery and D. Chopin, Epithelial cell plasticity in development and tumor progression, Cancer Metastasis Rev 18 (1999), 31-42.
90. L. Strizzi, C. Bianco, N. Normanno, M. Seno, C. Wecheselberger, B. Wallace-Jones, N.I. Khan, M. Hirota, Y. Sun, M. Sanicola and D.S. Salomon, Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary glands from MMTV-Cripto-1 transgenic mice, J Cell Physiol 201 (2004), 266-276.
91. C.F. Qi, D.S. Liscia, N. Normanno, G. Merlo, G.R. Johnson, W.J. Gullick, F. Ciardiello, T. Saeki, R. Brandt, N. Kim et al., Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas, Br J Cancer 69 (1994), 903-910.
92. N. Normanno, N. Kim, D. Wen, K. Smith, A.L. Harris, G. Plowman, G. Colletta, F. Ciardiello and D.S. Salomon, Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas, Breast Cancer Res Treat 35 (1995), 293-297.
93. L. Panico, A. D'Antonio, G. Salvatore, E. Mezza, G. Tortora, M. De Laurentiis, S. De Placido, T. Giordano, M. Merino, D.S. Salomon et al., Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues, Int J Cancer 65 (1996), 51-56.
94. C. Bianco, L. Strizzi, M. Mancino, A. Rehman, S. Hamada, K. Watanabe, A. De Luca, B. Jones, G. Balogh, J. Russo et al., Identification of cripto-1 as a novel serologic marker for breast and colon cancer, Clin Cancer Res 12 (2006), 5158-5164.
95. Y.P. Gong, P.M. Yarrow, H.L. Carmalt, S.Y. Kwun, C.W Kennedy, B.P. Lin, P.X. Xing and D.J. Gillett, Overexpression of Cripto and its prognostic significance in breast cancer: A study with long-term survival, Eur J Surg Oncol 33 (2007), 438-443.
96. R. Srinivasan, C.E. Gillett, D.M. Barnes and W.J. Gullick, Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers, Cancer Res 60 (2000), 1483-1487.
97. C. Bianco, S. Kannan, M. De Santis, M. Seno, C.K. Tang, I. Martinez-Lacaci, N. Kim, B. Wallace-Jones, M.E. Lippman, A.D. Ebert et al., Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor, J Biol Chem 274 (1999), 8624-8629.
98. L.M. Postovit, N.V. Margaryan, E.A. Seftor, D.A. Kirschmann, A. Lipavsky, W.W. Wheaton, D.E. Abbott, R.E.B. Seftor and M.J. Hendrix, Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells, Proc Natl Acad Sci USA (2008), In Press.
99. N. Normanno, G. Tortora, A. De Luca, G. Pomatico, A. Casamassimi, S. Agrawal, J. Mendelsohn, A.R. Bianco and F. Ciardiello, Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells, Oncol Rep 6 (1999), 1105-1109.